Star biotech Telix makes $1.2b revenue pledge
Telix Pharmaceuticals forecast revenue of up to $1.23 billion in fiscal 2025 ahead of a critical year for the ASX nuclear medicine company, which has three new cancer treatment products scheduled to hit the market. Telix, which makes most of its sales from …